|
humans |
319 |
|
female |
232 |
|
male |
231 |
|
adult |
206 |
|
middle aged |
192 |
|
animals |
169 |
|
aged |
154 |
|
adolescent |
118 |
|
immunohistochemistry |
117 |
|
cell line, tumor |
107 |
|
prognosis |
107 |
|
mice |
106 |
|
aged, 80 and over |
104 |
|
hong kong |
103 |
|
reverse transcriptase polymerase chain reaction |
97 |
|
hepatocellular carcinoma |
94 |
|
medical sciences |
87 |
|
gene expression regulation, neoplastic |
86 |
|
molecular sequence data |
84 |
|
base sequence |
82 |
|
apoptosis |
75 |
|
cell proliferation |
75 |
|
child |
75 |
|
hong kong - epidemiology |
74 |
|
dna methylation |
73 |
|
mutation |
73 |
|
genetic predisposition to disease |
64 |
|
neoplasm staging |
64 |
|
asian continental ancestry group - genetics |
63 |
|
child, preschool |
62 |
|
disease progression |
62 |
|
blotting, western |
60 |
|
cell line |
60 |
|
signal transduction |
60 |
|
treatment outcome |
60 |
|
neoplasm invasiveness |
59 |
|
transfection |
59 |
|
metastasis |
58 |
|
promoter regions, genetic |
58 |
|
gene expression |
57 |
|
infant |
56 |
|
up-regulation |
56 |
|
amino acid sequence |
55 |
|
tumor cells, cultured |
55 |
|
chinese |
54 |
|
polymerase chain reaction |
54 |
|
retrospective studies |
54 |
|
china |
53 |
|
gene expression profiling |
53 |
|
promoter regions, genetic - genetics |
53 |
|
survival analysis |
53 |
|
biopsy |
52 |
|
survival rate |
52 |
|
time factors |
52 |
|
nasopharyngeal carcinoma |
51 |
|
down-regulation |
50 |
|
follow-up studies |
49 |
|
mice, nude |
49 |
|
cell differentiation |
48 |
|
hcc |
46 |
|
rna, messenger - metabolism |
46 |
|
cells, cultured |
45 |
|
phenotype |
45 |
|
diagnosis, differential |
44 |
|
asian continental ancestry group |
43 |
|
case-control studies |
43 |
|
in situ hybridization |
43 |
|
covid-19 |
42 |
|
genotype |
42 |
|
transcription, genetic |
42 |
|
fatal outcome |
41 |
|
flow cytometry |
41 |
|
gene silencing |
41 |
|
rats |
41 |
|
recurrence |
41 |
|
sars-cov-2 |
41 |
|
cohort studies |
40 |
|
pregnancy |
40 |
|
prospective studies |
40 |
|
dna primers |
39 |
|
risk factors |
39 |
|
alleles |
38 |
|
biomarker |
38 |
|
cell cycle |
38 |
|
liver cancer |
38 |
|
mice, inbred balb c |
38 |
|
polymorphism, single nucleotide |
38 |
|
predictive value of tests |
38 |
|
in situ hybridization, fluorescence |
37 |
|
neoplasm metastasis |
37 |
|
neoplasm transplantation |
37 |
|
dna mutational analysis |
36 |
|
dna, neoplasm - genetics |
36 |
|
genes, tumor suppressor |
36 |
|
rna, messenger - genetics - metabolism |
36 |
|
sensitivity and specificity |
35 |
|
disease models, animal |
34 |
|
e-cadherin |
34 |
|
incidence |
34 |
|
polymorphism, genetic |
34 |
|
prevalence |
34 |
|
young adult |
34 |
|
interprofessional education |
33 |
|
biomarkers |
32 |
|
liver transplantation |
32 |
|
tomography, x-ray computed |
32 |
|
cell movement |
31 |
|
chemoresistance |
31 |
|
chromosome aberrations |
31 |
|
coronavirus |
31 |
|
diagnosis |
31 |
|
chemotherapy |
30 |
|
gene expression regulation |
30 |
|
liver neoplasms - metabolism - pathology |
30 |
|
microsatellite repeats |
30 |
|
neoplasm proteins - genetics - metabolism |
30 |
|
oligonucleotide array sequence analysis |
30 |
|
reproducibility of results |
30 |
|
transplantation, heterologous |
30 |
|
apoptosis - drug effects |
29 |
|
cell division |
29 |
|
dna-binding proteins - genetics |
29 |
|
immunosuppressive agents - therapeutic use |
29 |
|
karyotyping |
29 |
|
microscopy, electron |
29 |
|
mutation - genetics |
29 |
|
p53 |
29 |
|
phosphorylation |
29 |
|
promoter hypermethylation |
29 |
|
sequence analysis, dna |
29 |
|
age factors |
28 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
28 |
|
breast cancer |
28 |
|
cancer |
28 |
|
cell proliferation - drug effects |
28 |
|
chemicals and cas registry numbers |
28 |
|
disease-free survival |
28 |
|
gene expression regulation, neoplastic - genetics |
28 |
|
loss of heterozygosity |
28 |
|
partnership model |
28 |
|
social interaction anxiety |
28 |
|
tumor markers, biological - analysis |
28 |
|
tumor markers, biological - metabolism |
28 |
|
β-catenin |
28 |
|
animal experiment |
27 |
|
carcinoma, hepatocellular - metabolism - pathology |
27 |
|
china - ethnology |
27 |
|
gastric cancer |
27 |
|
gene amplification |
27 |
|
lymphatic metastasis |
27 |
|
neoplasm proteins - genetics |
27 |
|
nf-kappa b - metabolism |
27 |
|
tumor microenvironment |
27 |
|
epigenesis, genetic |
26 |
|
influenza |
26 |
|
intracellular signaling peptides and proteins |
26 |
|
mice, inbred c57bl |
26 |
|
microrna |
26 |
|
multivariate analysis |
26 |
|
proteomics |
26 |
|
risk assessment |
26 |
|
rna, messenger - analysis |
26 |
|
surgery |
26 |
|
dna, viral - analysis |
25 |
|
gene frequency |
25 |
|
immunoenzyme techniques |
25 |
|
neoplasm proteins - metabolism |
25 |
|
next-generation sequencing |
25 |
|
nucleic acid hybridization |
25 |
|
protein binding |
25 |
|
reference values |
25 |
|
repressor proteins |
25 |
|
signal transduction - physiology |
25 |
|
antineoplastic agents - pharmacology |
24 |
|
autoimmunity |
24 |
|
hepatitis b virus |
24 |
|
immunotherapy |
24 |
|
lung cancer |
24 |
|
mers-cov |
24 |
|
methylation |
24 |
|
oncology |
24 |
|
ovarian cancer |
24 |
|
pathogenesis |
24 |
|
protein structure, tertiary |
24 |
|
systemic lupus erythematosus |
24 |
|
tumor suppressor proteins - genetics - metabolism |
24 |
|
azacitidine - analogs & derivatives - pharmacology |
23 |
|
carcinoma, squamous cell - genetics |
23 |
|
cell line, transformed |
23 |
|
cell transformation, neoplastic - genetics |
23 |
|
cervical cancer |
23 |
|
chromosome deletion |
23 |
|
combined modality therapy |
23 |
|
drug therapy, combination |
23 |
|
genome-wide association study |
23 |
|
homozygote |
23 |
|
mice, knockout |
23 |
|
models, biological |
23 |
|
nf-κb signaling |
23 |
|
rats, sprague-dawley |
23 |
|
rna interference |
23 |
|
sex factors |
23 |
|
tumorigenesis |
23 |
|
virulence |
23 |
|
dna damage |
22 |
|
drug resistance, neoplasm |
22 |
|
gene expression regulation, neoplastic - drug effects |
22 |
|
heterozygote |
22 |
|
inflammation |
22 |
|
mitosis |
22 |
|
prognostic marker |
22 |
|
proliferation |
22 |
|
sequence deletion |
22 |
|
tissue distribution |
22 |
|
virus replication |
22 |
|
angiogenesis |
21 |
|
autoantibodies |
21 |
|
cadherins - metabolism |
21 |
|
carcinoma |
21 |
|
cell transformation, neoplastic |
21 |
|
chronic disease |
21 |
|
epstein-barr virus |
21 |
|
extracellular vesicles |
21 |
|
genes, p53 |
21 |
|
hela cells |
21 |
|
hepatectomy |
21 |
|
infant, newborn |
21 |
|
liver - pathology |
21 |
|
sequence homology, amino acid |
21 |
|
squamous cell carcinoma |
21 |
|
swine |
21 |
|
analysis of variance |
20 |
|
cell nucleus - metabolism |
20 |
|
clone cells |
20 |
|
cyclin-dependent kinase inhibitor p21 |
20 |
|
dose-response relationship, drug |
20 |
|
epidermal growth factor receptor |
20 |
|
epigenetics |
20 |
|
fluorescent antibody technique |
20 |
|
gene deletion |
20 |
|
intracellular signaling peptides and proteins - genetics |
20 |
|
microsatellite repeats - genetics |
20 |
|
phylogeny |
20 |
|
proto-oncogene proteins - genetics |
20 |
|
rna, viral - analysis |
20 |
|
survival |
20 |
|
t-lymphocytes - immunology |
20 |
|
whole-exome sequencing |
20 |
|
adenocarcinoma |
19 |
|
beta catenin |
19 |
|
biopsy, needle |
19 |
|
blotting, southern |
19 |
|
cell division - drug effects |
19 |
|
chemokines |
19 |
|
cross-sectional studies |
19 |
|
genome, viral |
19 |
|
herpesvirus 4, human - isolation & purification |
19 |
|
hypoxia |
19 |
|
immunophenotyping |
19 |
|
living donors |
19 |
|
nuclear proteins - metabolism |
19 |
|
polymorphism, restriction fragment length |
19 |
|
polymorphism, single nucleotide - genetics |
19 |
|
proteins - genetics |
19 |
|
transcription factors - genetics |
19 |
|
transcription factors - metabolism |
19 |
|
transplantation, homologous |
19 |
|
tumor suppressor proteins - metabolism |
19 |
|
adaptor proteins, signal transducing |
18 |
|
adaptor proteins, signal transducing - genetics - metabolism |
18 |
|
antigens, cd - genetics |
18 |
|
cell adhesion molecules - genetics |
18 |
|
cell transformation, neoplastic - genetics - metabolism |
18 |
|
china - epidemiology |
18 |
|
endometrial carcinoma |
18 |
|
gastroenterology |
18 |
|
gene knockdown techniques |
18 |
|
gestational trophoblastic disease |
18 |
|
hepatitis b |
18 |
|
homeodomain proteins - genetics - metabolism |
18 |
|
human papillomavirus |
18 |
|
inhibitor of differentiation protein 1 |
18 |
|
logistic models |
18 |
|
magnetic resonance imaging |
18 |
|
metabolomics |
18 |
|
mice, transgenic |
18 |
|
neoplasm recurrence, local |
18 |
|
organ size |
18 |
|
point mutation |
18 |
|
remission induction |
18 |
|
rna, messenger - genetics |
18 |
|
sars |
18 |
|
sars-cov |
18 |
|
treatment |
18 |
|
tumor suppressor protein p53 - metabolism |
18 |
|
alternative splicing |
17 |
|
asian |
17 |
|
cancer stemness |
17 |
|
carcinoma, hepatocellular - genetics - metabolism |
17 |
|
chi-square distribution |
17 |
|
chromosomes, human, pair 9 - genetics |
17 |
|
cpg islands |
17 |
|
diabetes |
17 |
|
dna, complementary - genetics |
17 |
|
enzyme activation |
17 |
|
exons |
17 |
|
gastroenterology medical sciences |
17 |
|
genes, p53 - genetics |
17 |
|
genetic predisposition to disease - genetics |
17 |
|
gestational age |
17 |
|
hydroxamic acids - pharmacology |
17 |
|
polymerase chain reaction - methods |
17 |
|
reverse transcriptase polymerase chain reaction - methods |
17 |
|
sorafenib |
17 |
|
telomerase |
17 |
|
testis |
17 |
|
transcription factors - genetics - metabolism |
17 |
|
translocation, genetic |
17 |
|
transmission |
17 |
|
acute disease |
16 |
|
adenocarcinoma - genetics |
16 |
|
alanine transaminase - blood |
16 |
|
brca1 protein - genetics |
16 |
|
burkholderia pseudomallei |
16 |
|
cadaver |
16 |
|
cadherins - genetics - metabolism |
16 |
|
cancer stem cell |
16 |
|
cancer stem cells |
16 |
|
carcinogenesis |
16 |
|
cell adhesion molecules - genetics - metabolism |
16 |
|
chromosomes, human, pair 11 |
16 |
|
comparative genomic hybridization |
16 |
|
cytology |
16 |
|
dendritic cells |
16 |
|
dna-binding proteins |
16 |
|
drug resistance |
16 |
|
enzyme inhibitors - pharmacology |
16 |
|
esophageal squamous cell carcinoma |
16 |
|
gene mutation |
16 |
|
genetic variation |
16 |
|
glycolysis |
16 |
|
graft survival |
16 |
|
heterogeneity |
16 |
|
hypermethylation |
16 |
|
in situ nick-end labeling |
16 |
|
liver neoplasms - pathology - surgery |
16 |
|
melioidosis |
16 |
|
nuclear proteins - genetics - metabolism |
16 |
|
odds ratio |
16 |
|
proto-oncogene proteins |
16 |
|
proto-oncogene proteins - metabolism |
16 |
|
receptors, cell surface - metabolism |
16 |
|
respiratory system - virology |
16 |
|
sequence alignment |
16 |
|
severity of illness index |
16 |
|
signal transduction - genetics |
16 |
|
statistics, nonparametric |
16 |
|
tandem repeat sequences |
16 |
|
tumor markers, biological - genetics - metabolism |
16 |
|
tumor suppressor |
16 |
|
wnt signaling |
16 |
|
animal model |
15 |
|
blotting, northern |
15 |
|
bone marrow - pathology |
15 |
|
bone marrow transplantation |
15 |
|
bronchi - cytology |
15 |
|
carcinogenicity tests |
15 |
|
cell division - physiology |
15 |
|
cell survival |
15 |
|
cell transformation, neoplastic - metabolism |
15 |
|
chromosome mapping |
15 |
|
confidence intervals |
15 |
|
cpg islands - genetics |
15 |
|
cyclosporine - therapeutic use |
15 |
|
dna-binding proteins - metabolism |
15 |
|
down-regulation - drug effects |
15 |
|
electrophoretic mobility shift assay |
15 |
|
helix-loop-helix motifs |
15 |
|
hong kong chinese |
15 |
|
l-lactate dehydrogenase - blood |
15 |
|
lectins, c-type - genetics - metabolism |
15 |
|
liver function tests |
15 |
|
lupus nephritis |
15 |
|
mitochondria |
15 |
|
nasopharyngeal neoplasms - genetics - metabolism - pathology |
15 |
|
neoplasm proteins - analysis |
15 |
|
neovascularization, pathologic |
15 |
|
nuclear proteins - biosynthesis - genetics |
15 |
|
peptidyl-prolyl-isomerase |
15 |
|
pin1 |
15 |
|
probability |
15 |
|
radiotherapy |
15 |
|
receptors, cell surface - genetics - metabolism |
15 |
|
reoperation |
15 |
|
rna, messenger - biosynthesis - genetics |
15 |
|
screening |
15 |
|
sequence homology, nucleic acid |
15 |
|
spectrometry, mass, matrix-assisted laser desorption-ionization |
15 |
|
thyroid gland |
15 |
|
tissue microarray |
15 |
|
tumor stem cell assay |
15 |
|
tumor suppressor gene |
15 |
|
tumor suppressor proteins |
15 |
|
vascular endothelial growth factor a - metabolism |
15 |
|
ablation |
14 |
|
antigens, cd - analysis |
14 |
|
antineoplastic agents - therapeutic use |
14 |
|
apoptosis - genetics |
14 |
|
asia |
14 |
|
association |
14 |
|
autopsy |
14 |
|
cancer therapy |
14 |
|
carcinoma, hepatocellular - metabolism |
14 |
|
cercopithecus aethiops |
14 |
|
choriocarcinoma |
14 |
|
cytokine |
14 |
|
cytokines |
14 |
|
differentiation |
14 |
|
dna modification methylases - antagonists & inhibitors |
14 |
|
dna primers - chemistry |
14 |
|
dna, viral - blood |
14 |
|
dna, viral - genetics |
14 |
|
enzyme-linked immunosorbent assay |
14 |
|
epithelial cells - pathology |
14 |
|
escc |
14 |
|
esophageal neoplasms - genetics - metabolism - pathology |
14 |
|
fallopian tube |
14 |
|
helicobacter pylori |
14 |
|
herpesvirus 4, human - genetics |
14 |
|
hsp70 heat-shock proteins - metabolism |
14 |
|
influenza, human - virology |
14 |
|
liver - metabolism |
14 |
|
liver neoplasms - genetics - metabolism |
14 |
|
liver neoplasms - genetics - metabolism - pathology |
14 |
|
lymph nodes - pathology |
14 |
|
microarray |
14 |
|
nasopharyngeal carcinoma (npc) |
14 |
|
nuclear proteins - genetics |
14 |
|
open reading frames - genetics |
14 |
|
ovary |
14 |
|
oxidative stress |
14 |
|
proportional hazards models |
14 |
|
proteasome endopeptidase complex - metabolism |
14 |
|
rna, neoplasm - analysis |
14 |
|
signal transduction - drug effects - physiology |
14 |
|
snp |
14 |
|
stomach neoplasms - genetics - pathology |
14 |
|
thyroid function tests |
14 |
|
tumor markers, biological - blood |
14 |
|
tumor markers, biological - genetics |
14 |
|
tumor-initiating cells |
14 |
|
up-regulation - genetics |
14 |
|
africa |
13 |
|
amino acid motifs |
13 |
|
animal |
13 |
|
antimetabolites, antineoplastic - pharmacology |
13 |
|
antioxidants |
13 |
|
autophagy |
13 |
|
avian |
13 |
|
beta catenin - metabolism |
13 |
|
bronchiectasis |
13 |
|
carcinoma, hepatocellular - mortality - pathology - surgery |
13 |
|
carcinoma, hepatocellular - pathology - surgery |
13 |
|
carcinoma, squamous cell - genetics - pathology |
13 |
|
cdna microarray |
13 |
|
cell cycle - drug effects |
13 |
|
chromosomes, human, pair 17 |
13 |
|
cirrhosis |
13 |
|
colorectal cancer |
13 |
|
conjunctiva - virology |
13 |
|
cyclin-dependent kinase inhibitor p27 |
13 |
|
cytokines - metabolism |
13 |
|
cytoplasm - metabolism |
13 |
|
dendritic cells - immunology |
13 |
|
dogs |
13 |
|
epigenesis, genetic - genetics |
13 |
|
esophageal cancer |
13 |
|
esophageal squamous cell carcinoma (escc) |
13 |
|
fibrosis |
13 |
|
heme oxygenase-1 |
13 |
|
histology |
13 |
|
immunoblotting |
13 |
|
immunoglobulin heavy chains - genetics |
13 |
|
immunosuppressive agents - pharmacology |
13 |
|
intercellular communication |
13 |
|
interferon |
13 |
|
kidney - pathology |
13 |
|
liver cirrhosis |
13 |
|
liver neoplasms - mortality - pathology - surgery |
13 |
|
liver transplant |
13 |
|
metabolism |
13 |
|
molecular biology |
13 |
|
organ culture techniques |
13 |
|
pathology |
13 |
|
platelet count |
13 |
|
ploidies |
13 |
|
prenatal diagnosis |
13 |
|
protein isoforms |
13 |
|
rhizopus microsporus |
13 |
|
ros |
13 |
|
severe acute respiratory syndrome |
13 |
|
sle |
13 |
|
smoking |
13 |
|
species index: fungi |
13 |
|
t-lymphocytes, cytotoxic - immunology |
13 |
|
tissue array analysis |
13 |
|
tubal ectopic pregnancy |
13 |
|
whole exome sequencing |
13 |
|
xenograft model antitumor assays |
13 |
|
acute myeloid leukemia |
12 |
|
adenocarcinoma - genetics - metabolism - pathology |
12 |
|
akt |
12 |
|
antibodies, monoclonal - immunology |
12 |
|
antigens, cd - metabolism |
12 |
|
antiviral agents - therapeutic use |
12 |
|
apobec-mediated signature |
12 |
|
birds |
12 |
|
brca1 |
12 |
|
cancer progression |
12 |
|
carcinoma - genetics - pathology |
12 |
|
carcinoma, hepatocellular - genetics |
12 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology |
12 |
|
carcinoma, squamous cell - genetics - metabolism - pathology |
12 |
|
carrier proteins - genetics - metabolism |
12 |
|
carrier proteins - metabolism |
12 |
|
caspases - metabolism |
12 |
|
cell movement - genetics |
12 |
|
children |
12 |
|
chromosomes, human, pair 13 - genetics |
12 |
|
cloning, molecular |
12 |
|
cricetinae |
12 |
|
cytogenetics |
12 |
|
deleted in liver cancer 2 |
12 |
|
dna, neoplasm - analysis |
12 |
|
dna-binding proteins - genetics - metabolism |
12 |
|
ebv |
12 |
|
ephrin-a2 - genetics |
12 |
|
epidemiology |
12 |
|
graft rejection |
12 |
|
hepatitis |
12 |
|
immunity, innate |
12 |
|
influenza a virus, h1n1 subtype - metabolism |
12 |
|
liver diseases - surgery |
12 |
|
liver neoplasms - genetics |
12 |
|
liver transplantation - adverse effects |
12 |
|
loh |
12 |
|
lupus erythematosus, systemic - genetics |
12 |
|
mapk |
12 |
|
membrane proteins - genetics - metabolism |
12 |
|
microcell-mediated chromosome transfer |
12 |
|
migration |
12 |
|
models, molecular |
12 |
|
mouse |
12 |
|
nasopharyngeal neoplasms - metabolism - pathology |
12 |
|
oncogene proteins - genetics |
12 |
|
paclitaxel - pharmacology |
12 |
|
papillomaviridae - genetics |
12 |
|
pediatric liver transplantation |
12 |
|
phosphorylation - drug effects |
12 |
|
plasma |
12 |
|
postoperative complications |
12 |
|
pregnancy trimester, first |
12 |
|
prognostic factors |
12 |
|
prostate cancer |
12 |
|
proteins - genetics - metabolism |
12 |
|
proteins - metabolism |
12 |
|
proto-oncogene proteins c-akt - metabolism |
12 |
|
rassf1a |
12 |
|
sars coronavirus |
12 |
|
severe acute respiratory syndrome - blood - genetics |
12 |
|
small extracellular vesicles |
12 |
|
somatic mutation landscape |
12 |
|
t cells |
12 |
|
therapeutics |
12 |
|
trans-activators - genetics |
12 |
|
tumor markers, biological |
12 |
|
tumor necrosis factor-alpha - genetics - metabolism |
12 |
|
tumor suppression |
12 |
|
uhrf1bp1 |
12 |
|
vascular endothelial growth factor |
12 |
|
zoonosis |
12 |
|
adenocarcinoma - metabolism - pathology |
11 |
|
adiponectin |
11 |
|
antibodies, monoclonal - diagnostic use |
11 |
|
antibodies, viral - biosynthesis |
11 |
|
antigens, cd3 - genetics |
11 |
|
antigens, cd44 - genetics - metabolism |
11 |
|
bcl-2-associated x protein |
11 |
|
biliary atresia |
11 |
|
bilirubin - blood |
11 |
|
bioinformatics |
11 |
|
body weight |
11 |
|
bone marrow |
11 |
|
cancer inhibition |
11 |
|
cancer metastasis |
11 |
|
carcinoma, hepatocellular - enzymology - pathology |
11 |
|
carcinoma, hepatocellular - etiology - genetics - metabolism |
11 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology - virology |
11 |
|
carcinoma, hepatocellular - pathology |
11 |
|
carrier proteins - genetics |
11 |
|
cd247 |
11 |
|
cell cycle proteins |
11 |
|
cell migration |
11 |
|
cell movement - physiology |
11 |
|
cho cells - virology |
11 |
|
chromosomes, human, pair 14 - genetics |
11 |
|
chromosomes, human, pair 3 |
11 |
|
codon - genetics |
11 |
|
controlled study |
11 |
|
cricetulus |
11 |
|
cyclin d1 - biosynthesis - genetics |
11 |
|
cytoskeletal proteins - genetics |
11 |
|
dna-binding proteins - biosynthesis - genetics |
11 |
|
drug screening |
11 |
|
epithelial-mesenchymal transition |
11 |
|
family health |
11 |
|
ferrets - virology |
11 |
|
genes, ras |
11 |
|
gestational trophoblastic neoplasia |
11 |
|
glutathione |
11 |
|
gwas |
11 |
|
h5n1 |
11 |
|
hematopoietic stem cell transplantation - adverse effects |
11 |
|
hepatitis b, chronic - complications |
11 |
|
high-intensity focused ultrasound |
11 |
|
human |
11 |
|
hydatidiform mole |
11 |
|
influenza a virus, h5n1 subtype - metabolism |
11 |
|
influenza virus |
11 |
|
interleukin-8 - biosynthesis - genetics |
11 |
|
intestine, small - physiology |
11 |
|
intraoperative complications - epidemiology |
11 |
|
kidney transplantation - adverse effects |
11 |
|
lamivudine - therapeutic use |
11 |
|
linkage disequilibrium |
11 |
|
liver |
11 |
|
liver neoplasms - enzymology - pathology |
11 |
|
liver neoplasms - genetics - metabolism - pathology - virology |
11 |
|
liver transplantation - immunology |
11 |
|
liver transplantation - statistics & numerical data |
11 |
|
longitudinal studies |
11 |
|
lung |
11 |
|
lung - physiology - virology |
11 |
|
lupus erythematosus, systemic - genetics - immunology |
11 |
|
macrophages - physiology |
11 |
|
microarray analysis - methods |
11 |
|
molecular pathology |
11 |
|
mutation, missense |
11 |
|
mutations |
11 |
|
myocardial ischemia injury |
11 |
|
neoplasm invasiveness - genetics |
11 |
|
neovascularization, pathologic - metabolism |
11 |
|
nidogen 1 |
11 |
|
nidogen-2 (nid2) |
11 |
|
nrf2 |
11 |
|
nuclear proteins |
11 |
|
nuclear proteins - analysis |
11 |
|
oncogene proteins, fusion - genetics |
11 |
|
oncogene proteins, viral - genetics |
11 |
|
ovarian neoplasms - genetics - pathology |
11 |
|
overexpression |
11 |
|
pedigree |
11 |
|
peptidylprolyl isomerase - biosynthesis - genetics |
11 |
|
pneumonia |
11 |
|
polymorphism, genetic - genetics |
11 |
|
pre‐metastatic niche |
11 |
|
protein stability |
11 |
|
protein-serine-threonine kinases - metabolism |
11 |
|
questionnaires |
11 |
|
ras proteins - metabolism |
11 |
|
reperfusion injury - pathology |
11 |
|
reverse transcriptase inhibitors - therapeutic use |
11 |
|
sars virus - metabolism - pathogenicity |
11 |
|
severe acute respiratory syndrome - epidemiology - genetics |
11 |
|
signaling |
11 |
|
species index: animalia |
11 |
|
stat3 |
11 |
|
stem cell |
11 |
|
stemness |
11 |
|
stomach neoplasms - genetics |
11 |
|
targeted therapy |
11 |
|
thyroiditis |
11 |
|
tissue donors |
11 |
|
tissue donors - statistics & numerical data |
11 |
|
transfection - methods |
11 |
|
tumor necrosis factor receptor 1 |
11 |
|
vascular endothelial growth factor a |
11 |
|
vascular endothelial growth factors |
11 |
|
vegf |
11 |
|
vero cells - virology |
11 |
|
x chromosome |
11 |
|
actins - metabolism |
10 |
|
acute lung injury |
10 |
|
alanine transaminase - metabolism |
10 |
|
alveolar epithelial cells |
10 |
|
amino acid substitution |
10 |
|
ampk |
10 |
|
antiangiogenesis |
10 |
|
antigen-presentation |
10 |
|
antigens, cd - blood |
10 |
|
antigens, cd - genetics - metabolism |
10 |
|
arhgap fusions |
10 |
|
aspartate aminotransferases - blood |
10 |
|
bcl-2 |
10 |
|
biobank |
10 |
|
blood transfusion |
10 |
|
blotting, western - methods |
10 |
|
bridging therapy |
10 |
|
carcinoma - metabolism - pathology |
10 |
|
carcinoma, hepatocellular - mortality - surgery |
10 |
|
case report |
10 |
|
caspase 3 |
10 |
|
cell cycle proteins - genetics |
10 |
|
cell growth |
10 |
|
cell movement - drug effects |
10 |
|
cell nucleus - ultrastructure |
10 |
|
cell separation |
10 |
|
chinese women |
10 |
|
chromosomal instability |
10 |
|
chromosome banding |
10 |
|
chromosome segregation |
10 |
|
chromosomes, human, pair 6 - genetics |
10 |
|
cisplatin - pharmacology |
10 |
|
cluster analysis |
10 |
|
colposcopy |
10 |
|
conjunctiva |
10 |
|
cyclin d1 - genetics |
10 |
|
cyclooxygenase 2 - biosynthesis - genetics |
10 |
|
cyclooxygenase 2 inhibitors |
10 |
|
cytokine and chemokine response |
10 |
|
cytokines - immunology |
10 |
|
dna |
10 |
|
dna - analysis |
10 |
|
dna - metabolism |
10 |
|
ebv genome |
10 |
|
endoscopy |
10 |
|
epithelial cells - drug effects - pathology |
10 |
|
esophageal neoplasms - genetics - metabolism |
10 |
|
evaluation studies as topic |
10 |
|
gastric adenocarcinoma |
10 |
|
gene expression regulation, leukemic |
10 |
|
genes, ras - genetics |
10 |
|
genotype-phenotype correlations |
10 |
|
germ-line mutation |
10 |
|
glycoproteins - metabolism |
10 |
|
h7n9 |
10 |
|
heterozygote detection |
10 |
|
histones - metabolism |
10 |
|
hpv |
10 |
|
hysterectomy |
10 |
|
immunoprecipitation |
10 |
|
influenza a virus, h1n1 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h1n2 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
|
influenza in birds - enzymology - immunology - virology |
10 |
|
influenza, human - enzymology - virology |
10 |
|
influenza, human - metabolism - transmission |
10 |
|
invasion |
10 |
|
keratins - metabolism |
10 |
|
liver neoplasms - mortality - surgery |
10 |
|
liver regeneration |
10 |
|
liver transplantation - methods |
10 |
|
liver transplantation - methods - statistics and numerical data |
10 |
|
living donors - supply and distribution |
10 |
|
lupus erythematosus, systemic - enzymology - genetics |
10 |
|
lymphoma |
10 |
|
mapping complex traits |
10 |
|
mesenchymal stromal cells |
10 |
|
nafld |
10 |
|
nasopharynx - virology |
10 |
|
necrosis |
10 |
|
neutralizing antibody |
10 |
|
new technology |
10 |
|
organ specificity |
10 |
|
organoid culture |
10 |
|
papillomavirus e7 proteins |
10 |
|
peptides - metabolism |
10 |
|
phosphatidylinositol 3-kinases - metabolism |
10 |
|
plasmids |
10 |
|
proliferating cell nuclear antigen |
10 |
|
random allocation |
10 |
|
reassortant viruses - isolation & purification |
10 |
|
repressor proteins - biosynthesis |
10 |
|
respiratory mucosa - virology |
10 |
|
rhoa mutations |
10 |
|
rna, neoplasm - metabolism |
10 |
|
rna, small interfering - pharmacology |
10 |
|
salvage therapy |
10 |
|
sars virus - genetics - metabolism |
10 |
|
sars virus - immunology |
10 |
|
scarce deceased donors |
10 |
|
sex characteristics |
10 |
|
specific |
10 |
|
stomach neoplasms - genetics - metabolism |
10 |
|
telomerase - metabolism |
10 |
|
tissue donors - supply and distribution |
10 |
|
transarterial chemoembolization |
10 |
|
transcriptome sequencing |
10 |
|
tumorigenicity |
10 |
|
venous infiltration |
10 |
|
viral replication |
10 |
|
viral tropism |
10 |
|
virus attachment |
10 |
|
adam proteins - biosynthesis - genetics - metabolism |
9 |
|
adenocarcinoma - diagnosis - pathology |
9 |
|
administration, oral |
9 |
|
adrenal cortex hormones - therapeutic use |
9 |
|
age of onset |
9 |
|
allelic imbalance |
9 |
|
alveolar fluid clearance |
9 |
|
antibodies, viral - blood |
9 |
|
apoptosis - physiology |
9 |
|
arginine methylation |
9 |
|
azathioprine - therapeutic use |
9 |
|
b cells |
9 |
|
biogenesis |
9 |
|
bone marrow transplantation - adverse effects |
9 |
|
brca2 |
9 |
|
breast neoplasms - genetics |
9 |
|
breast neoplasms - genetics - pathology |
9 |
|
bronchi - pathology |
9 |
|
cancer cell |
9 |
|
celecoxib |
9 |
|
cell cycle - genetics |
9 |
|
cell cycle arrest |
9 |
|
cell death - drug effects |
9 |
|
cervical intraepithelial neoplasia |
9 |
|
chemotherapy, adjuvant |
9 |
|
chromatography, high pressure liquid |
9 |
|
chromosomes, human, pair 12 |
9 |
|
chromosomes, human, pair 14 |
9 |
|
chromosomes, human, pair 5 |
9 |
|
chromosomes, human, pair 8 |
9 |
|
cytokines - biosynthesis |
9 |
|
disease outbreaks |
9 |
|
dna - chemistry |
9 |
|
dna methylation - drug effects |
9 |
|
dna probes |
9 |
|
dna replication |
9 |
|
dna, complementary - metabolism |
9 |
|
dna, mitochondrial - genetics |
9 |
|
dna, neoplasm - metabolism |
9 |
|
dual specificity phosphatase 6 - genetics - metabolism |
9 |
|
dual-specificity phosphatase 6 (dusp6) |
9 |
|
electrophoresis, gel, two-dimensional |
9 |
|
endothelial cells - cytology |
9 |
|
esophageal carcinoma |
9 |
|
esophageal neoplasms - blood supply - enzymology - genetics |
9 |
|
esophageal neoplasms - genetics |
9 |
|
euthyroid sick syndromes |
9 |
|
flavivirus |
9 |
|
gene |
9 |
|
gene dosage |
9 |
|
gene expression regulation - drug effects |
9 |
|
gene rearrangement |
9 |
|
gene therapy |
9 |
|
h5n1 influenza virus |
9 |
|
haplotypes |
9 |
|
hedgehog |
9 |
|
hepatitis b surface antigens - blood - immunology |
9 |
|
hepatitis b virus - genetics |
9 |
|
hospitals, university |
9 |
|
hydatidiform mole - genetics |
9 |
|
hyperinsulinism |
9 |
|
id proteins |
9 |
|
immortalization |
9 |
|
immunohistochemistry - methods |
9 |
|
inflammatory cytokines |
9 |
|
influenza a virus, h1n1 subtype - genetics - isolation and purification - physiology |
9 |
|
influenza a virus, h5n1 subtype - immunology - pathogenicity |
9 |
|
intestinal metaplasia |
9 |
|
ischemia-reperfusion injury |
9 |
|
kaplan-meier estimate |
9 |
|
keratins - analysis |
9 |
|
knowledge |
9 |
|
laparoscopy |
9 |
|
liver - chemistry - pathology |
9 |
|
liver - metabolism - pathology |
9 |
|
liver - pathology - virology |
9 |
|
liver diseases - epidemiology |
9 |
|
liver neoplasms - genetics - mortality - pathology |
9 |
|
liver neoplasms - genetics - pathology |
9 |
|
liver neoplasms - metabolism |
9 |
|
liver resection |
9 |
|
lymphoepithelioma-like carcinoma |
9 |
|
lymphoma - genetics |
9 |
|
lymphoma, follicular - genetics - pathology |
9 |
|
lymphoma, large b-cell, diffuse - genetics - pathology |
9 |
|
map kinase signaling system |
9 |
|
map kinase signaling system - drug effects - physiology |
9 |
|
mass screening - methods |
9 |
|
medicine & public health |
9 |
|
mesalazine |
9 |
|
mice, scid |
9 |
|
microsatellite instability |
9 |
|
mipol1 |
9 |
|
model |
9 |
|
mycobacterium tuberculosis |
9 |
|
nash |
9 |
|
nasopharyngeal neoplasms - blood supply - enzymology - genetics |
9 |
|
nitric oxide |
9 |
|
non-viral liver disease |
9 |
|
nuclear magnetic resonance, biomolecular |
9 |
|
olfactomedin-1 |
9 |
|
orchitis |
9 |
|
orthomyxoviridae infections - immunology - mortality - physiopathology - virology |
9 |
|
ovarian neoplasms - genetics |
9 |
|
phospholipids |
9 |
|
placenta - metabolism |
9 |
|
postoperative care |
9 |
|
postoperative complications - epidemiology |
9 |
|
precursor cell lymphoblastic leukemia-lymphoma - genetics |
9 |
|
prostatic neoplasms - pathology |
9 |
|
protein biosynthesis |
9 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
9 |
|
proto-oncogene proteins c-bcl-6 |
9 |
|
pten |
9 |
|
rat |
9 |
|
rats, inbred lew |
9 |
|
reactive oxygen species |
9 |
|
receptors, cell surface - genetics |
9 |
|
relapse |
9 |
|
rna - metabolism |
9 |
|
rna, neoplasm - genetics |
9 |
|
rna, small interfering |
9 |
|
sars virus - physiology |
9 |
|
spermatogenesis |
9 |
|
spermatogenesis - physiology |
9 |
|
sphingosine - analogs & derivatives |
9 |
|
steroid |
9 |
|
trans-activators |
9 |
|
trans-activators - genetics - metabolism |
9 |
|
trans-activators - metabolism |
9 |
|
tumor heterogeneity |
9 |
|
tumor necrosis factor-alpha - metabolism |
9 |
|
ultrastructure |
9 |
|
viral load |
9 |
|
wnt proteins - metabolism |
9 |
|
wound healing |
9 |
|
zanamivir |
9 |
|
zika |
9 |
|
2009 pandemic h1n1 influenza virus |
8 |
|
3t3 cells |
8 |
|
adaptor proteins, signal transducing - physiology |
8 |
|
adenocarcinoma - pathology |
8 |
|
adrenomedullin |
8 |
|
aneuploidy |
8 |
|
antibodies, monoclonal |
8 |
|
antigens, cd34 - metabolism |
8 |
|
ascitic fluid |
8 |
|
association study |
8 |
|
autoimmune disease |
8 |
|
bacteremia |
8 |
|
biliary atresia - complications - surgery |
8 |
|
biological markers - blood |
8 |
|
blood loss, surgical |
8 |
|
bone neoplasms - secondary |
8 |
|
bronchi - immunology - pathology |
8 |
|
cancer metabolism |
8 |
|
carcinoma, hepatocellular - metabolism - pathology - secondary |
8 |
|
carcinoma, squamous cell - genetics - metabolism |
8 |
|
carcinoma/metabolism |
8 |
|
carcinoma/secondary |
8 |
|
caveolin-1 |
8 |
|
cd133 |
8 |
|
cd56 |
8 |
|
cell adhesion |
8 |
|
cell adhesion molecules - genetics - physiology |
8 |
|
cell cycle - physiology |
8 |
|
cell cycle proteins - analysis - genetics |
8 |
|
cell cycle proteins - genetics - metabolism |
8 |
|
cell survival - drug effects - physiology |
8 |
|
characterization |
8 |
|
chemokine cxcl1 - physiology |
8 |
|
choriocarcinoma - genetics |
8 |
|
chromans - pharmacology |
8 |
|
chromosome 11q |
8 |
|
chromosome 8p |
8 |
|
chromosome aberrations - genetics |
8 |
|
chromosomes, human, pair 5 - genetics |
8 |
|
chromosomes, human, pair 7 |
8 |
|
cilia |
8 |
|
codon |
8 |
|
colonic neoplasms - genetics - metabolism - pathology |
8 |
|
complications of liver transplantation |
8 |
|
coronaviruses |
8 |
|
cyclin a2 |
8 |
|
cyclin-dependent kinase inhibitor p16 - genetics - metabolism |
8 |
|
cyclophosphamide |
8 |
|
cyclosporine |
8 |
|
cytogenetic analysis - methods |
8 |
|
cytokines - genetics - metabolism |
8 |
|
cytokines - genetics - physiology |
8 |
|
deoxyribonucleases, type ii site-specific |
8 |
|
diffusion magnetic resonance imaging |
8 |
|
disease severity |
8 |
|
dna primers - genetics |
8 |
|
drug combinations |
8 |
|
drug synergism |
8 |
|
dysmorphism |
8 |
